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Summary.-Wistar rats were sensitized to rat embryonic tissue by immunization
with irradiated (5000rad) rat embryo cells (2 x 106 s.c. + 1 x 106 i.p.) derived
from embryos aged 14-15 days, or by implantation of irradiated (5000 rad) tissue
grafts from these embryos. Three to five immunizations were given at weekly
intervals, and the rats were then challenged subcutaneously 7-10 days after the
final inoculum with minimal tumour-producing tumour cell doses. Immunization
with irradiated rat embryo cells failed to influence the growth and development
of tumour cells prepared from hepatoma D23 and D30, sarcoma Mc57, mammary
carcinoma AAF57 or cells prepared from spontaneously arising mammary car-
cinomata Sp4 and Spl5. Using adoptive transfer techniques, lymphoid cells from
embryo-sensitized rats, when used in a 3000 :1 ratio (lymphoid cells: tumour
cells), were shown effectively to retard the growth of hepatoma D23 in 3 out of 7
experiments performed. Similar adoptive transfer procedures proved ineffective
in preventing thegrowthof mammary carcinomaAAF57. Using in vitro cytotoxicity
tests, lymph node cells and spleen cells from embryo-immunized rats were shown
to be cytotoxic for several rat tumour cell targets: hepatoma D23 (7/10 tests),
sarcoma Mc7 (8/12 tests), mammary carcinoma AAF57 (2/2 tests) and Sp4 (3/4 tests),
and for 14-15-day-old rat embryo cells (5/10 tests). In comparative tests lymphoid
cells were relatively non-cytotoxic for 20-day-old rat embryo cells (1/6 tests) or
cells prepared from adult rat lung or kidney (1/10 tests). The role of embryonic
antigen(s) in tumour rejection is discussed.
IT IS NOW generally accepted that
many virus- and chemically-induced ani-
mal tumours express embryonic antigens
and these can be readily demonstrated
using in vitro techniques (Baldwin, Glaves
and Vose, 1973; Coggin and Anderson,
1974). Using syngeneic animal tumour
models, lymph node cells from multi-
parous pregnant animals have been shown
to be reactive towards chemically-induced
murine sarcoma cell lines, compared with
lymph node cells from age-matched virgin
controls (Brawn, 1970, 1971). Similar
findings have been reported by Girardi et
al. (1973) using DNA-virus-induced tu-
mours, and by Baldwin et al. (1973) in
chemically-induced rat hepatoma and
sarcoma systems.
Attempts by different groups of work-
ers to demonstrate transplant resistance
to tumours following immunization with
syngeneic embryonic tissue have not been
uniformly successful. Failure to induce
immunity to challenge with chemically-
induced tumour cells in inbred mice
immunized with syngeneic non-irradiated
foetal tissue has been reported (Buttle
and Frayne, 1967). In addition Ting,
Rodrigues and Herberman (1973) found
no protection to challenge with polyoma-
induced tumour cells, using mice immuniz-
ed with syngeneic irradiated mid-term
foetal tissue. In contrast with these
results are those of Coggin, Ambrose and
Anderson (1970) showing that the pre-
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induce transplantation resistance to SV40
hamster tumours, and similar findings
have recently been reported for chemi-
cally-induced tumours of mice, guinea-pigs
and rats (Grant and Wells, 1974; Le
Mevel and Wells, 1973; Grant, Ladisch
and Wells, 1974). Previous investiga-
tions in this laboratory into the immuno-
genicity of rat embryonic tissue have
failed to substantiate the view that em-
bryo-sensitized rats are capable of reject-
ing tumour cell implants (Baldwin, Glaves
and Vose, 1974). The disparity in the
results of different workers may, however,
be attributed to the different immuniza-
tion procedures adopted, and the results
presented here extend the initial observa-
tions to include a wide range ofchemically-
induced and spontaneous rat tumours,
incorporating procedures shownpreviously
to successfully induce tumour rejection
in the rat when tumour cells are used
for immunization. The nature of the
immune response in embryo-sensitized
rats was studied using in vitro assays to
detect cell-mediated immune responses,
and the relevance of these findings is
discussed in relation to in vivo tumour
rejection.
MATERIAL AND METHODS
Rats and tumours.-Hepatomata induced
in Wistar rats by oral administration of
4-dimethylaminoazobenzene (DAB) were
maintained by serial transplantation into
syngeneic rats of the same sex as the tumour
donor' (Baldwin and Barker, 1967). Rat
sarcomata were induced by s.c. injection
of 3-methylcholanthrene (Mc), and a mam-
mary carcinoma AAF57 by oral administra-
tion of 2-acetylaminofluorene as previously
described (Baldwin and Embleton, 1969).
Spontaneous rat mammary carcinomata and
sarcomata were implanted s.c. into inbred
Wistar rats, and the developing tumour line
maintained by serial transplantation.
Cell cultures.-Tumour cell culture3 were
prepared from in vivo transplanted tumour
lines. Single cell suspensions were obtained
by trypsin digestion (0-25%, DIFCO 1: 250)
and cultured in Eagle's MEM (Burroughs
Wellcome Laboratories, Beckenham, Kent)
supplemented with penicillin (100 iu/ml),
streptomycin (200 ,g/ml) and 10% bovine
serum. Normal adult rat lung and kidney
cells, and cells prepared from 14-15-day-old
rat embryos were cultured in Waymouth's
Medium supplemented with 20% foetal
bovine serum and antibiotics. All cultures
were subcultured when confluent.
Lymphoid cells (lymph node cells, LNC).-
The cervical, axillary and mesenteric lymph
nodes were removed aseptically from multi-
parous or embryo-immunized rats, together
with lymph nodes from normal control rats.
The lymph nodes were chopped finely and
pressed through a 120-gauge stainless steel
wire mesh, and the cells washed three times
with Eagle's MEM (HEPES buffered) supple-
mented with 5% foetal bovin serum and
finally resuspended in Eagle's MEM (HEPES
buffered) to the desired concentration.
Spleen cell suspensions were prepared
in a similar manner and the red blood cells
removed by flash lysis (Rees and Potter,
1973). The viable cell count was determined
by trypan blue exclusion, and the cells used
immediately in experiments.
Microcytotoxicity tests.-In vitro cell cul-
tures were trypsinized and seeded into Cooke
microtest plates (M29 ART) at 100-200 cells
per well (0-2 ml). Following incubation at
37°C for 24 h, the medium was replaced
by 0X2 ml of LNC or spleen cell suspension
prepared from test (embryo-sensitized) or
control (non-sensitized) rats. The plates
were incubated at 37°C for 60 min and
foetal bovine serum added to afinal concentra-
tion of 10% (V/V). Following incubation
at 37°C for 48 h the plates were washed with
saline, and the remaining cells fixed with
methanol, stained with 0-01% crystal violet
and cell number per well determined.
All tests were performed using LNC at
5 x 105 and 2-5 x 105 cells per well, and
spleen cells at 3 x 105 and 1-5 x 105 cells
per well.
Immunization procedures
Irradiated rat embryo cells.-Rat embryos
aged 14-15 days (Witschi. 1956) were re-
moved aseptically from multiparous pregnant
rats, finely minced and pressed through an
80-gauge stainless steel mesh, and suspended
in Hanks' balanced salt solution. The
viable cell count was determined and ad-
justed to 1 x 107 cells/ml. Cells prepared
by this method were 70-90% viable. Spleen
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cells were prepared as described above, and
used as normal control cells. The cell
suspensions were then irradiated (5000 rad)
and inoculated into groups of rats; 02 ml
of rat embryo or adult rat spleen cells was
inoculated s.c., and 01 ml of cells i.p.,
weekly for up to 5 weeks. Immunizations
were carried out within 1 h of the embryos
being removed. Ten days after the final
immunizing dose, rats were challenged sub-
cutaneously with a minimal tumour-produc-
ing dose, and the incidence and growth of
tumours recorded up to the sixth week.
Irradiated rat embryo grafts.-Rat em-
bryos (14-15 days old) were removed
aseptically, sectioned into 4 fragments and
irradiated (5000 rad); the fragments were im-
planted into anaesthetized rats, at weekly
intervals, for up to 5 weeks. Control rats
received irradiated adult rat spleen tissue
fragments. Both groups of rats were chal-
lenged 10 days after the final implantation,
with a minimal tumour cell inoculum.
Embryoma excision. Single cell suspen-
sions were prepared from 14-15-day-old
rat embryos and 5 x 106 viable cells inoculat-
ed s.c. into groups of rats. The resulting
embryomata were then excised at 1-2 cm
in diameter, and 10 days following excision
the rats were used in experiments.
Adoptive transfer experiments.-LNC and
spleen cells were prepared from embryo-
sensitized rats and mixed together with
trypsinized rat tumour cells prepared from
solid tumour fragments, in ratios of 500: 1
to 5000 : 1 (lymphoid cells : tumour cells).
The mixture (0-2 ml) was then inoculated
into normal recipients and the incidence
of tumours recorded over a period of 5 weeks.
Conitrol rats received tumour cells and
lymphoid cells prepared from normal (non-
sensitized) rats or rats having received
implants of normal adult rat tissue.
RESULTS
Incidence of tumours following immuniza-
tion with irradiated (5000 rad) 14-15-day-
old rat embryo cells
The incidence of tumours in rats
immunized with up to 5 s.c. and i.p.
inoculations of irradiated 14-15-day-old
rat embryo cells is shown in Table I.
No significant difference in incidence was
recorded for embryo-immunized rats chal-
lenged subcutaneously with hepatoma
D23 cells (Table I, Expts. 1 and 2).
In 4 subsequent experiments (Table I,
Expts. 3-6), and using tumours ofvarying
histological types, no protection to chal-
lenge was afforded by prior immunization
with irradiated rat embryo cells. In only
one experiment, using hepatoma D30
cells for challenge, was there a reduction
in the rate of tumour growth, although
the final tumour incidence in both test
and controls was similar (Table I, Expt. 3).
Incidence of tumours following immuniza-
tion with irradiated (5000 rad) 14-15-day-
old rat embryo grafts
Rats having received 4-5 irradiated
14-15-day-old rat embryo grafts, were
challenged s.c. with tumour cells from
chemically-induced hepatoma D23 and
mammary carcinoma AAF57, and spon-
taneous sarcomata (Sp24 and Sp4l) and
mammary carcinomata (Sp4 and Sp15).
The incidence of tumours is shown in
Table II. Only embryo-immunized rats
challenged with mammary carcinoma
AAF57 showed any significant protection
to tumour challenge (Table II, Expt. 2).
This effect was partially abrogated by
increasing the AAF57 challenge dose to
1 X 104 cells (Table II, Expt. 3). How-
ever in a subsequent experiment with a
challenge dose of 1 x 103 AAF57 tumour
cells, protection to tumour challenge was
not obtained (Table II, Expt. 4).
Adoptive transfer experiments
Lymph node cells (LNC) and spleen
cells prepared from rats immunized with
embryonic tissue, either by weekly inocu-
lation of irradiated 14-15-day-old rat
embryo cells or by embryoma excision,
were adoptively transferred to normal
rats in a mixed inoculum with tumour
cells. Multiparous pregnant rats were
also used as a source of embryo-sensitized
lymphoid cells for adoptive transfer ex-
periments. The incidence of tumours in
rats receiving tumour cells + lymphoid
cells from either embryo-sensitized or
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TABLE I.-Incidence of Tumours in Rats Immutnized with Irradiated (5000 rad) 14-15-
Day-old Rat Embryo Cells
Tumour
Hepatoma D23
Hepatoma D23
Hepatoma D30
Sarcoma Mc57
Mammary carcinoma Sp4
Mammary carcinoma SpI5
Tumour cell
challenge
dose*
5x 103 cells
5x 103 cells
1 X 104 cells
5x 105 cells
2 x 104 cells
1 x 103 cells
Incidence of tumourst
ControlII Embryo-immunized§
8/10: 6/10
9/10 7/10
9/10 10/10
5/5 5/5
9/10 7/10
8/10 9/10
* Tumour cells inoculated s.c. in 0*2 ml.
t Final incidence of tumours 4-6 weeks after tumour cell challenge.
1 Number developing tumours/number inoculated.
§ Rats immunized with 5 inoculations of 14-15-day-old rat embryo cells (2 x 106 cells s.c. and 1 x 106
cells i.p.) at weekly intervals.
11 Rats given 5 inoculations of normal female rat spleen cells (2 x 106 cells s.c. and 1 x 106 cells i.p.) at
weekly intervals.
TABLE II.-Incidence ofTurmour,s in Rats Immunized with Irradiated (5000 rad)
14-15-Day-old Rat Embryo Grafts
Tumour
Hepatoma D23
Mammary carcinoma AAF57
Mammary carcinoma AAF57
Mammary carcinoma AAF57
Sarcoma Sp24
Sarcoma Sp4l
Mammary carcinoma Sp4
Mammary carcinoma SpI5
Tumour cell
challenge dose*
5 x 103 cells
1 x 103 cells
1 X 104 cells
1 x 103 cells
1 X 104 cells
5 x 105 cells
2 x 104 cells
1 x 103 cells
Incidence of tumourst
Control¶ Embryo-immunized§
4/4: 5/5
5/5 1/511
5/5 3/5
4/5 4/4
5/9 9/10
10/10 10/10
7/10 9/9
8/10 6/9
* Tumour cells inoculated s.c. in 0-2 ml.
t Final incidence of tumours 4-6 weeks after tumour cell challenge.
$ Number developing tumours/number inoculated.
§ 4-5 grafts of rat embryos aged 14-16 days.
T 4-5 grafts normal female rat spleen.
Significant reduction in the incidence of tumour (P < 0 05).
TABLE III.-Incidence of Tumours in Ratsfollowing Adoptive Transfer of Lymph Node
Cells (LNC) or Spleen Cells from Rats Sensitized with 14-15-Day-old Rat Embryo
Tissue
Tumour
Hepatoma D23
Hepatoma D23
Hepatoma D23
Hepatoma D23
Hepatoma D23
Hepatoma D23
Hepatoma D23
Mammary carcinoma AAF57
Mammary carcinoma AAF57
Effector cell donor
LNC, x 5 irradiated embryo cells
LNC, embryoma excised
Spleen cells, x 5 irradiated embryo cells
Spleen cells, embryoma excised
LNC, multiparous rat
LNC, multiparous rat
Spleen cells, multiparous rat
LNC, x 4 irradiated embryo cells
Spleen cells, x 4 irradiated embryo cells
* Effector cells, derived from the lymph node or spleen of normal female or embryo-sensitized rats,
mixed together with 5 x 103 tumour cells in 0 2 ml and inoculated s.c. into normal rats.
t Final incidence of tumours 4-6 weeks after adoptive transfer.
t Significant reduction in the incidence and growth rate of tumours (P< 0 05).
Experiment
1
2
3
4
5
6
Experiment
1
2
3
4
5
6
7
8
Experi-
ment
1
2
3
4
5
6
7
8
9
Effector
cell:
tumour
cell ratio*
3000: 1
5000 :1
3000 :1
500: 1
3000 :1
3000 :1
3000 :1
3000 :1
2000 :1
Incidence of
tumourt
Control Test
rats rats
5/5 5/5
5/5 5/5
4/5 1/5:
4/5 5/5 6/6 0/5:
3/5 5/5 5/5 2/4:
5/5 5/5
5/5 5/5
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TABLE IV.-In Vitro Cytotoxicity ofLymph Node or Spleen Cellsfrom Embryo-sensitized
Rats*, for Cells Derivedfrom Rat Tumour, Embryo or Adutlt Tiss3ue
Target cells
Hepatoma D23 cells
Sarcoma Mc7 cells
Mammary carcinoma AAF57 cells
Mammary carcinoma Sp4 cells
15-day-old rat embryo cells
20-day-old rat embryo cells
Normal adult rat kiclney or lung
No. of positive
testst
7/10
8/12
2/2
3/4
5/10
1/6
1/10
Mfean 0O cell reduction (range)
+ve test -ve test
45 (20, 82) 8 (11, 6)
48 (29, 62) 3 (-22, +15)
58 (39, 77)
62 (28, 96) 6
32 (23, 40) 8 (-13, +26)
32 -12 (-100, + 28)
41 -19 (-54, +12)
* Rats immunized with irradiated 14-15-day-old rat embryo cells (2 x 106 cells s.c., and 1 x 106 cells
i.p.) weekly for 3-5 weeks, or by embryoma excision.
t No. ofpositive tests (P<0-05)/total no. of tests performed.
normal (non-sensitized) controls, is shown
in Table III. Using hepatoma D23 cells
and LNC or spleen cells from embryo-
sensitized rats, inhibition of tumour
growth was observed in only 3 out of 7
experiments performed (Table III, Expts.
1-7). Lymphoid cells from rats im-
munized with irradiated rat embryo cells
failed to inhibit the development and
growth of mammary carcinoma AAF57
cells used at a 3000: 1 or 2000: 1 ratio
(lymphoid cells: tumour cells).
In vitro cytotoxicity of lymphoid cells from
embryo-immunized rats
Spleen cells and LNC taken from
embryoma-excised rats and rats immun-
ized with 3-5 weekly inoculations of
14-15-day-old rat embryo cells were tested
for in vitro cytotoxicity towards tumour,
embryo and normal rat target cells
(Table IV). Significant cytotoxicity (P
0.05) was demonstrated against target
cells derived from hepatoma D23 (7/10
tests), sarcoma Mc7 (8/12 tests), mam-
mary carcinomata AAF57 (2/2 tests)
and Sp4 (3/4 tests), and with cells from
14-15-day-old rat embryo cells (5/10
tests). With target cells derived from
20-day-old rat embryo tissue or adult
rat kidney or lung tissue, significant
reactivity could only be shown in 1 out
of 6 tests with 20-day-old rat embryo
cells as targets, and 1 out of 10 tests
using adult rat lung and kidney cells as
targets.
DISCUSSION
Previous investigations have shown
the presence of embryonic antigens at
the tumour cell surface to be a feature
frequently accompanying malignant trans-
formation. This can be demonstrated
by the reactivity of multiparous rat
lymph node cells towards tumour cells,
using the in vitro microcytotoxicity test
(Baldwin et al., 1973; Rees, Bray, Robins
and Baldwin, 1975). In addition the
results presented here show that rats
immunized against 14-15-day-old rat em-
bryonic tissue possess lymphoid cells
reactive towards tumour-associated cell
surface antigens. This reactivity was
not shown towards cells derived from
adult rat tissue or 20-day-old rat embryos.
Although cytotoxicity can be readily
demonstrated, there is no apparent cor-
relation of immune status, as measured
by in vitro tests, with the ability of the
host to reject a subcutaneous challenge
with tumour cells. The effect on tumour
growth of pre-immunization with em-
bryonic tissue has been reported by
several groups of workers and contra-
dictory results have been obtained, show-
ing both enhancement of tumour growth
and rejection (Grant and Wells, 1974;
Grant et al., 1974; Le Mevel and Wells,
1973; Parmiani and Lembo, 1974; Ben-
dick, Borenfreund and Stonehill, 1973;
Baldwin et al., 1973). This may in part
reflect differences between the tumour
systems studied as well as differences
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in the embryonic tissue used, or its
method of preparation. The present
study was designed further to evaluate
the immune status of rats immunized
with rat embryonic tissue. Experimental
rat tumours of various histological types
were used, and methods previously shown
to induce transplant immunity to tumour
challenge were incorporated into the
study. The results presented here show
tumour rejection responses in rats im-
munized with irradiated 14-15-day-old
rat embryonic tissue or cells, to be an
inconsistent event, in both the direct
challenge experiments and cell transfer
tests This low frequency of reactivity
was shown using direct challenge and
adoptive cell transfer with hepatoma
D23 and mammary carcinoma AAF57
tumour systems, and is consistent with
previous results obtained with chemically-
induced rat sarcomata (Baldwin et al.,
1974). Immunity to challenge with spon-
taneous rat mammary carcinomata and
sarcomata could not be demonstrated
in rats sensitized to rat embryonic tissue,
although these tumours have been shown
to express embryonic components at
their cell surface (Baldwin and Embleton,
1974).
Possible explanations as to why em-
bryo-immunized rats fail consistently to
limit the growth of tumours known to
express embryonic components may be
proposed. Firstly, threshold differences
in immunity may determine the fate
of tumour cells implanted s.c., and the
level of immunity may be directly de-
pendent on the amount of tumour-related
embryonic antigen present in the im-
munizing inoculum. The way in which
the antigens are presented to the host
may also be an important factor, not only
in determining the level, but also the
nature ofthe immune responses. Tumour-
associated embryonic antigen expression
on rat embryo cells has been shown to
be phase-specific, being maximally ex-
pressed on rat embryos aged 14-15 days.
Although the tissue used in the present
study for immunization was derived
from 14-15-day-old rat embryos, this
does not eliminate the possibility that
variation in the immunogenicity of tissue
preparations may have occurred, and as
such may have affected the nature of
the immune response. Coggin and Ander-
son (1974) have suggested that embryonic
tissue derived from multiparous animals
is less likely to evoke tumour resistance,
compared with embryonic tissue prepared
from primiparous animals. This is un-
likely to be the case in the rat model,
since previous work has established no
increased resistance following immuniza-
tion with primiparous rat embryonic
tissue (Baldwin et al., 1974).
Recent work has shown that pre-
sensitization to 14-15-day-old rat em-
bryonic tissue limits the growth oftumour
cells inoculated i.v. into rats (Rees, Shah
and Baldwin, 1975; Shah et al., in pre-
paration). In these experiments rats
were immunized by embryoma excision,
or by 3 weekly inoculations of irradiated
rat embryo cells or extranuclear mem-
branes prepared from 14-15-day-old rat
embryos. These immunizations effec-
tively prevented the growth of pulmonary
tumours compared with non-immunized
control rats, or rats immunized with
adult rat tissue or 19-20-day-old em-
bryonic tissue. This suggests that the
route by which tumour cells are implanted
may be an important variable in demon-
strating anti-tumour responses. Such re-
sults, compared with those presented
here, indicate inhibition of pulmonary
tumour growth to be a more sensitive
assay system for measuring immunity
in animals immunized with embryonic
tissue. The mechanism of this inhibition
has not yet been fully established, and is
currently under investigation.
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